Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

@article{Barrett2017DiabeticMD,
  title={Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.},
  author={Eugene J. Barrett and Zhen-qi Liu and Mogher Khamaisi and George L King and Ronald Klein and Barbara E. K. Klein and Timothy M. Hughes and Suzanne Craft and Barry I. Freedman and Donald W. Bowden and Aaron I Vinik and Carolina M Casellini},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2017},
  volume={102 12},
  pages={
          4343-4410
        }
}
Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs. Our understanding of the genesis of this injury and of potential interventions to prevent, limit, or reverse injury/dysfunction is continuously evolving. This statement reviews biochemical/cellular pathways involved in facilitating and abrogating microvascular injury. The statement summarizes the types of injury/dysfunction that occur in the three classical diabetes microvascular target tissues, the eye… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 685 REFERENCES

Effect of 3444 candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): 3445 a randomised placebo-controlled trial

  • AK Sjolie, R Klein, +5 authors N. Chaturvedi
  • 2008
Highly Influential
61 Excerpts

Guideline for Diabetes and CKD: 2012 Update

  • KDOQI Clinical Practic
  • American Journal of 4492 Kidney Diseases
  • 2012
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…